Correlation Between Viracta Therapeutics and Novartis
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Novartis AG ADR, you can compare the effects of market volatilities on Viracta Therapeutics and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Novartis.
Diversification Opportunities for Viracta Therapeutics and Novartis
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Viracta and Novartis is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Novartis AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG ADR and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG ADR has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Novartis go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and Novartis
Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Novartis. In addition to that, Viracta Therapeutics is 5.5 times more volatile than Novartis AG ADR. It trades about -0.06 of its total potential returns per unit of risk. Novartis AG ADR is currently generating about 0.06 per unit of volatility. If you would invest 7,841 in Novartis AG ADR on August 23, 2024 and sell it today you would earn a total of 2,468 from holding Novartis AG ADR or generate 31.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viracta Therapeutics vs. Novartis AG ADR
Performance |
| Timeline |
| Viracta Therapeutics |
| Novartis AG ADR |
Viracta Therapeutics and Novartis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viracta Therapeutics and Novartis
The main advantage of trading using opposite Viracta Therapeutics and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.| Viracta Therapeutics vs. Kiora Pharmaceuticals | Viracta Therapeutics vs. ZyVersa Therapeutics | Viracta Therapeutics vs. Sonnet Biotherapeutics Holdings | Viracta Therapeutics vs. Zura Bio Limited |
| Novartis vs. AstraZeneca PLC ADR | Novartis vs. GlaxoSmithKline PLC ADR | Novartis vs. Roche Holding Ltd | Novartis vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |